| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/06/2008 | EP1885008A1 Monoamine compound, charge-transporting material, and organic electroluminescent device |
| 02/06/2008 | EP1883636A1 Substituted piperidine antagonist of hi receptor to be used for the treatment of rhinitis |
| 02/06/2008 | EP1883632A1 Vanilloid receptor ligands and their use in treatments |
| 02/06/2008 | EP1883631A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof |
| 02/06/2008 | EP1883627A1 Bir domain binding compounds |
| 02/06/2008 | EP1883621A2 Methods of preparing 3-cyano-quinolines and intermediates made thereby |
| 02/06/2008 | EP1883451A2 Substituted indole compounds having nos inhibitory activity |
| 02/06/2008 | CN101119996A Chemical compouns |
| 02/06/2008 | CN101119987A Novel compounds |
| 02/06/2008 | CN101119986A Optically active tetrahydronaphthalene derivative |
| 02/06/2008 | CN101119973A 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 02/06/2008 | CN101119970A Azadecalin glucocorticoid receptor modulators |
| 02/06/2008 | CN101119968A Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 02/06/2008 | CN101119724A Substituted pyrazoles as modulators of chemokine receptors |
| 02/06/2008 | CN101117336A 7-(4-oxime-3-amino-1-piperidine) quinoline carboxylic acid derivative and method for making same |
| 02/06/2008 | CN100366620C Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine) |
| 02/06/2008 | CN100366618C Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 02/06/2008 | CN100366616C Novel bicyclic inhibitors of hormone sensitive lipase |
| 02/06/2008 | CN100366614C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 02/06/2008 | CN100366612C 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as aspartic specifity cysteine proteinase inhibitors |
| 02/06/2008 | CN100366252C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion |
| 02/05/2008 | US7326793 From a pyrrolidinone compound; coloring high molecular weight material |
| 02/05/2008 | US7326792 4,5-Diphenyl-2-amino-4,5-dihydro-imidazole derivatives useful as pharmaceutical agents in treatment or prevention of diseases having an inflammatory component, including inflammatory bowel disease, rheumatoid arthritis and diseases associated with central nervous system, such as Alzheimer's disease |
| 02/05/2008 | US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326788 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/05/2008 | US7326784 Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 02/05/2008 | US7326728 Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof |
| 02/05/2008 | US7326724 Salts of omeprazole and esomeprazole I |
| 02/05/2008 | US7326723 Autoimmune disease; antiinflammatory agents |
| 02/05/2008 | US7326721 Doxepin analogs and methods of use thereof |
| 02/05/2008 | US7326720 Phenyl- and pyridylpiperidines with TNF activity |
| 02/05/2008 | US7326710 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent |
| 02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
| 02/05/2008 | US7326706 Pyrazine modulators of cannabinoid receptors |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2349227C Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 02/05/2008 | CA2315685C Molecular dispersion composition with enhanced bioavailability |
| 02/05/2008 | CA2281642C Substituted 2,4-diaminopyrimidines |
| 02/05/2008 | CA2205406C Novel benzyl pyrimidines |
| 01/31/2008 | WO2008014361A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/31/2008 | WO2008014291A2 Compounds and compositions as hedgehog signaling pathway modulators |
| 01/31/2008 | WO2008014252A2 Iap inhibitors |
| 01/31/2008 | WO2008014247A2 4 -arylalkoxymethyl-4- phenyl piperidines and their use as neurokinin receptor antagonists for the treatment of cns disorders |
| 01/31/2008 | WO2008013660A2 Inhibitors of advanced glycation end products |
| 01/31/2008 | WO2008013494A1 Quinoline derivatives as p2x7 receptor antagonist and their use in the treatment of rheumatoid arthritis, osteoarthritis, copd and ibd |
| 01/31/2008 | WO2008013213A1 Prodrug of cinnamide compound |
| 01/31/2008 | WO2008012623A1 Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 01/31/2008 | WO2008012524A1 Substituted aniline derivatives |
| 01/31/2008 | WO2008012441A2 Linear pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 01/31/2008 | WO2008012418A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/31/2008 | WO2008012326A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/31/2008 | WO2007120574A3 Diaryl substituted alkanes |
| 01/31/2008 | WO2007109459A3 Pyridines and pyridine n-oxides as modulators of thrombin |
| 01/31/2008 | WO2007100282A8 New salts of an indole derivative and their use in medicine |
| 01/31/2008 | WO2007098507A3 Compositions and methods for inhibition of the jak pathway |
| 01/31/2008 | WO2007002559A8 Pyrazole based lxr modulators |
| 01/31/2008 | US20080027227 reacting amlodipine with nicotinic acid in an organic solvent to form amlodipine nicotinate salt; and recrystallizing formed salt with a mixture of solvents containing methanol and isopropanol or water and isopropanol Photostability; enhanced pharmacological activity |
| 01/31/2008 | US20080027226 Electroluminescent Device |
| 01/31/2008 | US20080027110 Indolyl-3-glyoxylic acid derivatives having antitumor action |
| 01/31/2008 | US20080027099 Bicyclic heteroaryl inhibitors of pde4 |
| 01/31/2008 | US20080027093 Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/31/2008 | US20080027092 1-Acetic Acid-Indole, -Indazole and -Benzimidazole Derivatives Useful for the Treatment of Respiratory Disorders |
| 01/31/2008 | US20080027085 2-(Pyridin-2-Yl)-Pyrimidines and Their Use for Controlling Harmful Fungi |
| 01/31/2008 | US20080027080 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/31/2008 | US20080027076 Pyrimidines With Tie2 (Tek) Activity |
| 01/31/2008 | US20080027074 3-(2-piperazin-1-yl-phenylsulfanyl)-1H-indole; 3-(2-piperazin-1-yl-phenylsulfanyl)-1H-indole-7-carboxylic acid methyl ester; attention deficit hyperactivity disorder (ADHD); serotonin, norepinephrine and/or dopamine reuptake inhibitors reuptake inhibitors |
| 01/31/2008 | US20080027071 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 01/31/2008 | US20080027069 Quinazoline compounds |
| 01/31/2008 | US20080027067 Heterocyclic derivatives as modulators of ion channels |
| 01/31/2008 | US20080027066 Arylpiperazinyl Compounds |
| 01/31/2008 | US20080027065 G protein coupled receptor inhibitors (Gpr38) such as 6-[(4-fluorophenyl)oxy]-N-methyl-N-(4-{[(3S)-3-methyl-1-piperazinyl]methyl}phenyl)-3-pyridinecarboxamide for treatment of gastric stasis in an enterally fed patient |
| 01/31/2008 | US20080027061 omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors |
| 01/31/2008 | US20080027058 Mitotic Kinesin Inhibitors |
| 01/31/2008 | US20080027056 Substituted heterocyclic ethers and their use in cns disorders |
| 01/31/2008 | US20080027055 1-Substituted indoles, and benzimidazoles additionally substituted with an amino ligand, e.g., 1-[(5-chlorothien-2-yl)sulfonyl]-5-[2-(piperidin-1-yl)ethoxy]-1H-indole; treating schizophrenia, depression, attention deficit disorder, Alzheimer's disease and Parkinson's disease |
| 01/31/2008 | US20080027054 4-Substituted quinolines as antitumor agents |
| 01/31/2008 | US20080027050 Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio) |
| 01/31/2008 | US20080027047 Compounds that modulate HSP90 activity and methods for identifying same |
| 01/31/2008 | US20080027037 Cyclic compounds |
| 01/31/2008 | US20080027035 Dpp-Iv Inhibitors |
| 01/31/2008 | US20080027001 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 01/31/2008 | DE102006033109A1 Substituierte Heteroaryl-Derivate Substituted heteroaryl derivatives |
| 01/31/2008 | CA2659192A1 Substituted heterocyclic ethers and their use in cns disorders |
| 01/31/2008 | CA2658913A1 Substituted aniline derivatives |
| 01/31/2008 | CA2658782A1 Compounds and compositions as hedgehog pathway modulators |
| 01/31/2008 | CA2658624A1 Pyridazine and pyrrole compounds, processes for obtaining them and applications thereof |
| 01/31/2008 | CA2658534A1 Linear pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 01/31/2008 | CA2658037A1 Prodrug of cinnamide compound |
| 01/31/2008 | CA2657200A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/31/2008 | CA2656716A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 01/30/2008 | EP1882689A1 Tri- or tetra-substituted-3-aminopyrrolidine derivatives |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1882685A1 Method for producing asymmetric tetrasubstituted carbon atom-containing compound |
| 01/30/2008 | EP1881978A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives |
| 01/30/2008 | EP1881977A1 Histone deacetylase inhibitors |
| 01/30/2008 | EP1881976A1 Substituted amide derivatives as protein kinase inhibitors |